Newsgather
GeriNHS to Provide Lifesaving Drugs for Children with Rare Muscle-Wasting Disease
NHS to Provide Lifesaving Drugs for Children with Rare Muscle-Wasting Disease
Sağlık
Guardian UK14.05.2026Sağlık4 dk okumaUnited Kingdom

NHS to Provide Lifesaving Drugs for Children with Rare Muscle-Wasting Disease

Hızlı Bakış

NICE recommends NHS funding for nusinersen (Spinraza) and risdiplam (Evrysdi) for spinal muscular atrophy (SMA) patients in England, Wales, and Northern Ireland, offering improved survival and quality of life for hundreds of children with this rare genetic disorder.

Yapay zekâ özeti

Yazı boyutu

Hundreds of children with a rare muscle-wasting disease will be able to receive two drugs that can improve their survival in a move parents hailed as a “lifeline”. The National Institute for Health and Care Excellence (Nice) has published final draft guidance recommending that any patient who would benefit can have either drug. ... (Full article text preserved with paragraph breaks)

İlgili Konular

Bu haber ilk olarak şurada yayınlandı: Guardian UK.

İlgili Haberler

Bu konuda daha fazlaSpinal Muscular Atrophy